Joseph Ciaffoni Collegium Pharmaceutical, Inc (COLL) insider trading activity

Joseph Ciaffoni is President and CEO of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 444,867 shares of COLL, which is worth approximately $17.3 Million. The most recent transaction as insider was on Dec 01, 2022, when has been sold 76,653 shares (Common Stock) at a price of $22.47 per share, resulting in proceeds of $1,722,392. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 445K

0% 3M change

61.77% 12M change

Total Value Held $17.3 Million

Joseph Ciaffoni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2022	SELL Open market or private sale	$1,722,392 $22.47 p/Share	76,653 Reduced 19.16%	323,453 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$1,218,782 $15.9 p/Share	76,653 Added 16.08%	400,106 Common Stock
Nov 28 2022	SELL Open market or private sale	$946 $22.0 p/Share	43 Reduced 0.01%	323,453 Common Stock
Nov 28 2022	BUY Exercise of conversion of derivative security	$683 $15.9 p/Share	43 Added 0.01%	323,496 Common Stock
Nov 22 2022	SELL Open market or private sale	$1,430 $22.0 p/Share	65 Reduced 0.02%	323,453 Common Stock
Nov 22 2022	BUY Exercise of conversion of derivative security	$1,033 $15.9 p/Share	65 Added 0.02%	323,518 Common Stock
Nov 18 2022	SELL Open market or private sale	$43,797 $22.02 p/Share	1,989 Reduced 0.61%	323,453 Common Stock
Nov 18 2022	BUY Exercise of conversion of derivative security	$31,625 $15.9 p/Share	1,989 Added 0.61%	325,442 Common Stock
Jul 01 2022	SELL Payment of exercise price or tax liability	$25,315 $18.16 p/Share	1,394 Reduced 0.43%	323,453 Common Stock
Mar 01 2022	SELL Open market or private sale	$1,423,719 $18.71 p/Share	76,094 Reduced 18.98%	324,847 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$934,337 $17.63 p/Share	52,997 Reduced 11.67%	400,941 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	190,034 Added 29.51%	453,938 Common Stock
Jan 03 2022	SELL Payment of exercise price or tax liability	$20,361 $18.68 p/Share	1,090 Reduced 0.41%	263,904 Common Stock
Aug 10 2021	SELL Payment of exercise price or tax liability	$26,376 $19.03 p/Share	1,386 Reduced 0.52%	264,994 Common Stock
Jul 01 2021	SELL Payment of exercise price or tax liability	$33,442 $23.99 p/Share	1,394 Reduced 0.52%	266,380 Common Stock
Jun 02 2021	SELL Open market or private sale	$133,689 $22.81 p/Share	5,861 Reduced 2.14%	267,774 Common Stock
Jun 01 2021	SELL Payment of exercise price or tax liability	$106,989 $22.9 p/Share	4,672 Reduced 1.68%	273,635 Common Stock
Jun 01 2021	SELL Open market or private sale	$374,822 $23.13 p/Share	16,205 Reduced 5.59%	273,635 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$133,205 $8.22 p/Share	16,205 Added 5.29%	289,840 Common Stock
Mar 01 2021	SELL Open market or private sale	$1,485,130 $22.93 p/Share	64,768 Reduced 18.88%	278,307 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$399,624 $8.22 p/Share	48,616 Added 12.41%	343,075 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$617,247 $25.95 p/Share	23,786 Reduced 7.47%	294,459 Common Stock
Jan 19 2021	BUY Grant, award, or other acquisition	-	133,989 Added 29.63%	318,245 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$21,833 $20.03 p/Share	1,090 Reduced 0.59%	184,256 Common Stock
Nov 30 2020	SELL Payment of exercise price or tax liability	$86,385 $18.49 p/Share	4,672 Reduced 2.46%	185,346 Common Stock

Joseph Ciaffoni

President and CEO

Stoughton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Value

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

Operation

Value

Type

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL

Account